|
CN114007646B
(zh)
*
|
2019-06-25 |
2024-05-10 |
南京金斯瑞生物科技有限公司 |
抗cd47/抗tigit双特异抗体及其制备方法和应用
|
|
CN114072426B
(zh)
*
|
2019-07-08 |
2024-01-26 |
南京金斯瑞生物科技有限公司 |
抗cd47/抗pd-1双特异抗体及其制备方法和应用
|
|
CN114096564A
(zh)
*
|
2019-07-16 |
2022-02-25 |
南京金斯瑞生物科技有限公司 |
抗cd47/抗ctla-4双特异抗体及其制备方法和应用
|
|
AU2020315598B2
(en)
|
2019-07-16 |
2024-12-12 |
Gilead Sciences, Inc. |
HIV vaccines and methods of making and using
|
|
EP4039711A4
(en)
*
|
2019-07-23 |
2023-11-15 |
Nanjing GenScript Biotech Co., Ltd. |
Anti-cd47/anti-lag-3 bispecific antibody, preparation method therefor and use thereof
|
|
TW202108631A
(zh)
*
|
2019-08-21 |
2021-03-01 |
大陸商和鉑醫藥(上海)有限責任公司 |
一種抗cd47抗原結合蛋白及其應用
|
|
JP7808546B2
(ja)
|
2019-09-03 |
2026-01-29 |
中山康方生物医▲藥▼有限公司 |
抗cd47モノクローナル抗体及びその使用
|
|
PH12022550835A1
(en)
|
2019-10-18 |
2023-07-03 |
Forty Seven Inc |
Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemia
|
|
NZ786589A
(en)
|
2019-10-31 |
2025-03-28 |
Forty Seven Llc |
Anti-cd47 and anti-cd20 based treatment of blood cancer
|
|
JP7369297B2
(ja)
|
2019-12-17 |
2023-10-25 |
ファイザー・インク |
Cd47、pd-l1に特異的な抗体、およびその使用
|
|
CN115362003B
(zh)
|
2019-12-24 |
2024-03-22 |
卡尔那生物科学株式会社 |
二酰基甘油激酶调节化合物
|
|
TWI890283B
(zh)
|
2020-02-14 |
2025-07-11 |
美商基利科學股份有限公司 |
結合ccr8之抗體及融合蛋白及其用途
|
|
CN112679611B
(zh)
*
|
2021-01-18 |
2022-06-10 |
倍而达药业(苏州)有限公司 |
人源化cd47抗体或其抗原结合片段及应用
|
|
US12091681B2
(en)
|
2020-03-27 |
2024-09-17 |
Mendus B.V. |
Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
|
|
TWI869582B
(zh)
*
|
2020-04-10 |
2025-01-11 |
大陸商和記黃埔醫藥(上海)有限公司 |
抗cd47抗體及其用途
|
|
WO2022003568A1
(en)
|
2020-06-30 |
2022-01-06 |
Dcprime B.V. |
Use of leukemia-derived cells in ovarian cancer vaccines
|
|
WO2022010806A1
(en)
*
|
2020-07-06 |
2022-01-13 |
ALX Oncology Inc. |
Methods for reducing the interference of drugs that bind therapeutic targets expressed on blood cells in serological assays
|
|
CN120040592A
(zh)
*
|
2020-07-31 |
2025-05-27 |
百奥泰生物制药股份有限公司 |
Cd47抗体及其应用
|
|
CA3187837A1
(en)
*
|
2020-08-04 |
2022-02-10 |
Exelixis, Inc. |
Cd47 binding agents and uses thereof
|
|
KR20230079393A
(ko)
*
|
2020-09-28 |
2023-06-07 |
상하이 헨리우스 바이오테크, 인크. |
항 cd47 항체 및 사용 방법
|
|
KR102757518B1
(ko)
*
|
2020-12-07 |
2025-01-21 |
(주)이노베이션바이오 |
Cd47에 특이적인 항체 및 이의 용도
|
|
WO2022140659A2
(en)
*
|
2020-12-23 |
2022-06-30 |
D-10 Therapeutics, Inc. |
Anti-cd47 antibodies and uses thereof
|
|
US20250277031A1
(en)
*
|
2021-01-08 |
2025-09-04 |
Beijing Hanmi Pharmaceutical Co., Ltd. |
Antibody specifically binding to cd47 and antigen-binding fragment thereof
|
|
WO2022190058A1
(en)
|
2021-03-12 |
2022-09-15 |
Dcprime B.V. |
Methods of vaccination and use of cd47 blockade
|
|
TW202302145A
(zh)
|
2021-04-14 |
2023-01-16 |
美商基利科學股份有限公司 |
CD47/SIRPα結合及NEDD8活化酶E1調節次單元之共抑制以用於治療癌症
|
|
JP7651018B2
(ja)
|
2021-06-23 |
2025-03-25 |
ギリアード サイエンシーズ, インコーポレイテッド |
ジアシルグリセロールキナーゼ調節化合物
|
|
MX2023014762A
(es)
|
2021-06-23 |
2024-01-15 |
Gilead Sciences Inc |
Compuestos moduladores de diacilglicerol quinasa.
|
|
EP4359413A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
CN117355531A
(zh)
|
2021-06-23 |
2024-01-05 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
|
KR102757524B1
(ko)
*
|
2021-06-30 |
2025-01-21 |
(주)이노베이션바이오 |
Cd47에 특이적인 인간화 항체 및 이를 포함하는 cd47 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
US20240336681A1
(en)
*
|
2021-07-30 |
2024-10-10 |
Ludwig-Maximilians-Universität München |
Anti-cd47 antibodies and use thereof
|
|
EP4423078A1
(en)
|
2021-10-28 |
2024-09-04 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
|
PE20241186A1
(es)
|
2021-10-29 |
2024-06-03 |
Gilead Sciences Inc |
Compuestos de cd73
|
|
US20240124412A1
(en)
|
2021-12-22 |
2024-04-18 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
CN118488948A
(zh)
|
2021-12-22 |
2024-08-13 |
吉利德科学公司 |
Ikaros锌指家族降解剂及其用途
|
|
CA3248911A1
(en)
|
2022-01-28 |
2023-08-03 |
Gilead Sciences, Inc. |
POLY(ADENOSINE DIPHOSPHATE-RIBOSE) POLYMERASE 7 INHIBITORS
|
|
PL4245756T3
(pl)
|
2022-03-17 |
2025-02-17 |
Gilead Sciences, Inc. |
Środki degradujące palec cynkowy z rodziny ikaros i ich zastosowania
|
|
AU2023240346A1
(en)
|
2022-03-24 |
2024-09-19 |
Gilead Sciences, Inc. |
Combination therapy for treating trop-2 expressing cancers
|
|
TWI876305B
(zh)
|
2022-04-05 |
2025-03-11 |
美商基利科學股份有限公司 |
用於治療結腸直腸癌之組合療法
|
|
EP4511127A1
(en)
|
2022-04-21 |
2025-02-26 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
CN117257935A
(zh)
*
|
2022-06-21 |
2023-12-22 |
广东菲鹏制药股份有限公司 |
一种含抗cd47抗体或其抗原结合片段的制剂及其制备方法和应用
|
|
WO2024006929A1
(en)
|
2022-07-01 |
2024-01-04 |
Gilead Sciences, Inc. |
Cd73 compounds
|
|
CA3259040A1
(en)
|
2022-07-12 |
2024-01-18 |
Gilead Sciences, Inc. |
HIV Immunogenic Polypeptides and Vaccines and Their Uses
|
|
CN115932271A
(zh)
*
|
2022-09-02 |
2023-04-07 |
东曜药业有限公司 |
一种cd47抗体的试剂组合物及其应用
|
|
US20240091351A1
(en)
|
2022-09-21 |
2024-03-21 |
Gilead Sciences, Inc. |
FOCAL IONIZING RADIATION AND CD47/SIRPa DISRUPTION ANTICANCER COMBINATION THERAPY
|
|
CN119968212A
(zh)
*
|
2022-10-14 |
2025-05-09 |
南京传奇生物科技有限公司 |
靶向cd47的抗体及其用途
|
|
EP4638436A1
(en)
|
2022-12-22 |
2025-10-29 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
CN120584133A
(zh)
*
|
2022-12-29 |
2025-09-02 |
上海复宏汉霖生物技术股份有限公司 |
抗cd47抗体及使用方法
|
|
WO2024215754A1
(en)
|
2023-04-11 |
2024-10-17 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
PE20260121A1
(es)
|
2023-04-21 |
2026-01-16 |
Gilead Sciences Inc |
Inhibidores de prmt5 y usos de los mismos
|
|
JP2026522894A
(ja)
|
2023-06-30 |
2026-07-09 |
ギリアード サイエンシーズ, インコーポレイテッド |
Kras調節化合物
|
|
CN121568935A
(zh)
|
2023-07-26 |
2026-02-24 |
吉利德科学公司 |
Parp7抑制剂
|
|
AU2024297978A1
(en)
|
2023-07-26 |
2026-02-05 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
EP4774280A1
(en)
|
2023-09-08 |
2026-07-15 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20250109147A1
(en)
|
2023-09-08 |
2025-04-03 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
WO2025096589A1
(en)
|
2023-11-03 |
2025-05-08 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
US20250230168A1
(en)
|
2023-12-22 |
2025-07-17 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
WO2025245003A1
(en)
|
2024-05-21 |
2025-11-27 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
US20260098049A1
(en)
|
2024-08-12 |
2026-04-09 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
US20260130893A1
(en)
|
2024-10-21 |
2026-05-14 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2026136515A1
(en)
|
2024-12-19 |
2026-06-25 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|